The Experimental and Redox Therapeutics program focuses on:

• Advancing approaches that exploit vulnerabilities in tumors, target redox pathways, and preserve normal tissue function.
• Evaluating innovative therapeutic, drug delivery, and theranostic strategies using state-of-the-art model systems.
• Translating preclinical discoveries into clinical trials and support their commercialization.